Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Spero Therapeutics, Inc. | Director | Common Stock | 55K | $79.8K | $1.45 | May 29, 2024 | Direct |
Larimar Therapeutics, Inc. | Director | Common Stock | 2K | $22K | $11.00 | Feb 14, 2024 | Direct |
Larimar Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 19K | May 29, 2024 | Direct | ||
Orchard Therapeutics plc | Title: President & Chief Operating Officer | Ordinary Shares | 0 | $0.46 | Jan 24, 2024 | Direct | |
Orchard Therapeutics plc | Title: President & Chief Operating Officer | Stock Option (Right to Buy) | 0 | Jan 24, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LRMR | Larimar Therapeutics, Inc. | May 29, 2024 | 1 | $0 | 4 | May 31, 2024 | Director |
SPRO | Spero Therapeutics, Inc. | May 29, 2024 | 1 | $0 | 4 | May 30, 2024 | Director |
LRMR | Larimar Therapeutics, Inc. | Feb 14, 2024 | 1 | $22K | 4 | Feb 15, 2024 | Director |
ORTX | Orchard Therapeutics plc | Jan 24, 2024 | 11 | $0 | 4 | Jan 24, 2024 | Title: President & Chief Operating Officer |
SPRO | Spero Therapeutics, Inc. | Oct 5, 2023 | 1 | $0 | 4 | Oct 10, 2023 | Director |
LRMR | Larimar Therapeutics, Inc. | May 9, 2023 | 1 | $0 | 4 | May 11, 2023 | Director |
ORTX | Orchard Therapeutics plc | Mar 10, 2023 | 2 | $9.18K | 4 | Mar 14, 2023 | Title: President & Chief Operating Officer |
ORTX | Orchard Therapeutics plc | Mar 1, 2023 | 2 | $0 | 4 | Mar 3, 2023 | Title: President & Chief Operating Officer |
ORTX | Orchard Therapeutics plc | Feb 9, 2023 | 2 | $9.18K | 4 | Feb 13, 2023 | Title: President & Chief Operating Officer |
ORTX | Orchard Therapeutics plc | Oct 4, 2022 | 16 | $0 | 4 | Oct 6, 2022 | Title: President & Chief Operating Officer |
SPRO | Spero Therapeutics, Inc. | Sep 15, 2022 | 1 | $0 | 4 | Sep 19, 2022 | Director |
ORTX | Orchard Therapeutics plc | Jun 1, 2022 | 1 | $0 | 4 | Jun 3, 2022 | Title: President & Chief Operating Officer |
LRMR | Larimar Therapeutics, Inc. | May 10, 2022 | 1 | $0 | 4 | May 12, 2022 | Director |
ORTX | Orchard Therapeutics plc | Apr 1, 2022 | 1 | $7.47K | 4 | Apr 4, 2022 | Title: President & Chief Operating Officer |
SPRO | Spero Therapeutics, Inc. | Jan 5, 2022 | 1 | $20K | 4 | Jan 7, 2022 | Director |
SPRO | Spero Therapeutics, Inc. | Aug 17, 2021 | 1 | $0 | 4 | Aug 18, 2021 | Director |
LRMR | Larimar Therapeutics, Inc. | May 12, 2021 | 1 | $0 | 4 | May 17, 2021 | Director |